Arkis BioSciences® provides minimally invasive instrumentation and advanced catheters for a variety of neuro-surgical treatments. The Arkis portfolio has been engineered for the surgeon to improve patient care by implementing innovative designs with advanced manufacturing techniques. (Product images to the side of text)
Arkis is the exclusive provider of Endexo® polymer-impregnated cerebrospinal ﬂuid (CSF) catheters for external drainage. The company is further developing additional groundbreaking technology which advances shunt regulation and provides for non-invasive tele-diagnostics.
Arkis was founded by three entrepreneurs with a passion to enhance the treatments for intracranial hypertension. The company has since expanded its offerings to enable a variety of minimally invasive procedures. Arkis is led by co-founder and CEO, Chad Seaver, working closely with the company’s CMO, James Killeﬀer, M.D. The business began operations in 2013 and is headquartered in Knoxville, Tennessee.
Chairman of the Board
President, Innova Memphis, early-stage Venture Capital firm
Former, Senior Vice-President, Smith and Nephew Orthopaedics
Over 20 years of medical device expertise with General Electric, Johnson & Johnson
CEO & Board Member
Chief Executive Officer of Arkis BioSciences responsible for business organization and development, capital fundraising, finance, product development leadership, and commercialization.
Sixteen years prior medical device experience, including ten years senior management, leading the development and commercialization of new devices with private-to-public ventures and global conglomerates.